🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of the study is to evaluate whether bemnifosbuvir (BEM) is effe...
Status
Completed
Location
Atea Study Site
Start Date
2022-11-25
Trial ID
NCT05629962
Treatments Being Tested
To Assess the Effect of Hepatic Impairment on the Pharmacokinetics of Bemni...
Status
Completed
Location
Atea Study Site Orlando Clinical Research Center
Start Date
2023-01-30
Trial ID
NCT05724693
Treatments Being Tested
To Assess the Effect of Severe Hepatic or Renal Impairment on the Pharmacok...
Status
Completed
Location
Atea Study Site
Start Date
2025-04-09
Trial ID
NCT06911320
Treatments Being Tested
Drug-drug interaction study of Ruzasvir and Bemnifosbuvir...
Status
Completed
Location
Atea Study Site
Start Date
2023-01-30
Trial ID
NCT05731843
Treatments Being Tested
This study will assess the safety, tolerability and pharmacokinetics (PK) o...
Status
Completed
Location
Atea Study Site
Start Date
2023-04-26
Trial ID
NCT05905497
Treatments Being Tested
This study will assess comparative bioavailability and effect of food on a ...
Status
Completed
Location
Atea Study Site
Start Date
2023-12-14
Trial ID
NCT06204679
This is an open-label trial to evaluate safety and efficacy of treatment wi...
Status
Completed
Location
Atea Study Site
Start Date
2023-05-30
Trial ID
NCT05904470
Treatments Being Tested
This study will assess the effects of Bemnifosbuvir on cardiac repolarizati...
Status
Completed
Location
Atea Study Site
Start Date
2023-04-25
Trial ID
NCT05905484
Treatments Being Tested
Drug-drug interaction study between Bemnifosbuvir/Ruzasvir and Digoxin or R...
Status
Completed
Location
Atea Study Site
Start Date
2025-04-08
Trial ID
NCT06921941
Drug-drug interaction study of Biktarvy and Bemnifosbuvir/Ruzasvir...
Status
Completed
Location
Atea Study Site
Start Date
2024-04-15
Trial ID
NCT06356194
Treatments Being Tested